๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Therapeutic apheresis in autoimmune and rheumatic diseases

โœ Scribed by Anna P. Koo

Publisher
John Wiley and Sons
Year
2000
Tongue
English
Weight
59 KB
Volume
15
Category
Article
ISSN
0733-2459

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Therapeutic apheresis in renal and metab
Therapeutic apheresis in renal and metabolic diseases
โœ Jeffrey L. Winters; Alvaro A. Pineda; Bruce C. McLeod; Kathleen M. Grima ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 122 KB ๐Ÿ‘ 1 views
APOPTOSIS IN AUTOIMMUNE AND NON-AUTOIMMU
APOPTOSIS IN AUTOIMMUNE AND NON-AUTOIMMUNE THYROID DISEASE
โœ LUDGATE, MARIAN; JASANI, BHARAT ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 239 KB ๐Ÿ‘ 1 views

The elimination of autoreactive T cells in the thymus involves the process of programmed cell death. Animal model studies, using the lpr and gld strains of mice, have identified FAS receptor (FAS) and FAS ligand (FAS-L) as important components of this mechanism. Whether FAS and FAS-L are also implic

An overview of therapeutic apheresis in
An overview of therapeutic apheresis in pediatrics
โœ Dolores M. Galacki ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 22 KB ๐Ÿ‘ 1 views

Therapeutic apheresis in pediatrics requires selected modifications due to the child's smaller size, blood volume, and developmental age. Red blood cell priming is used to prevent dilution of the child's hematocrit from the normal saline prime. Continuous flow cell separators maintain isovolemia. Di